Axogen completes marketing submission for Avance Nerve Graft [Seeking Alpha]
Axogen, Inc. (AXGN)
Last axogen, inc. earnings: 2/24 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.axogeninc.com
Company Research
Source: Seeking Alpha
at marketing approval for its Avance Nerve Graft, a surgical solution for peripheral nerve repair. The FDA's feedback on whether the BLA is accepted for review is expected within roughly 60 days of submission. Simultaneously, the regulator is expected to communicate its decision on whether to grant the BLA its standard or priority review. Axogen ( AXGN ) has requested priority review for the BLA, which could reduce the review timeline to six months from the standard 10-month duration. The company expects that the BLA will be on track for a decision on approvability between April and September 2025. “We will continue to collaborate closely with the FDA as they review our application,” remarked Axogen ( AXGN ) CEO Michael Dale. Recommended For You More Trending News Recommended For You More Trending News About AXGN Stock Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
AXGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXGN alerts
High impacting Axogen, Inc. news events
Weekly update
A roundup of the hottest topics
AXGN
News
- AxoGen Reports Strong Q3 2024 Revenue Growth [Yahoo! Finance]Yahoo! Finance
- Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements [Yahoo! Finance]Yahoo! Finance
- Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA UpdateGlobeNewswire
- Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024GlobeNewswire
- AxoGen, Inc. (NASDAQ: AXGN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
AXGN
Earnings
- 11/7/24 - Beat
AXGN
Sec Filings
- 11/14/24 - Form SC
- 11/7/24 - Form SC
- 11/7/24 - Form 10-Q
- AXGN's page on the SEC website